Clinical Trial

Combating Related Epidemics in HCV

Study acronym: CREST
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a two-arm cluster randomized control trial to evaluate the effectiveness of a single-visit point-of-care (POC) test and treat bundle (intervention arm) compared to the current standard-of-care (SOC, control arm). 1:1 randomization occurs at the site level.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-06
Trial Details
NCT Number NCT07560046
Lead Sponsor Duke University
Collaborators: Yale University, West Virginia University, University of San Diego, Cepheid, Gilead Sciences, Abbott, National Institute of Allergy and Infectious Diseases (NIAID), Flinders University International Centre for Point-of-care Testing, Kirby Institute
Conditions HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV), HEPATITIS C (HCV)
Enrollment 1,280 participants
Start Date 2026-08-01
Primary Completion 2030-11-30 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05